Interesting: The excruciatingly detailed timeline on how the Teladoc-Livongo deal came together. Started with a call between Teladoc SVP Corp Dev Andrew Turitz and Livongo CFO Lee Shapiro. Shapiro told Tullman about it. Talked to board. 5 days later Gorevic-Shaprio/Tullman call.

Maybe more interesting (but unsurprising) that Teladoc was considering three other sizable acquisition targets. Livongo was one of four.

On July 3 -- Teladoc's board decided Livongo was its best bet for moving into chronic care. Makes me wonder if Company A and Company B were also chronic care companies like Omada? Or were they other telemedicine companies like AmWell? Or one of each?

Teladoc sent Livongo its first proposal on July 22 and it had a target announcement date of August 6, which they ended up beating by one day. It went through numerous revisions, right up to the last minute... the deal was announced August 5th, 2020.

One of the more important steps along the way was captured by @chrissyfarr in her @cnbc piece about how the deal came together -- the meeting between Tullman, Taneja and Gorevic in-person in Detroit.

https://www.cnbc.com/2020/08/05/livongo-teladoc-deal-reached-over-months-during-coronavirus-pandemic.html

Today's filing reveals a bit about what was said:

Here are a few highlights from the companies' investor presentation today:

Teladoc's "strategic vision" mapped out with this odd chart:

Teladongo also put together a number of metrics for the combined company:

"Synergy" metrics related to future revenue expectations:

The companies also provided more color and examples for how cross-selling might look:

Last one from me for now... some customer journeys for how Teladoc services could flow into Livongo's and vice-versa...

I'll add more to this thread as I dig into the rest of the S-4, which you can read here:

https://www.sec.gov/Archives/edgar/data/1477449/000114036120019690/nt10014322x1_s4.htm#tRF